Latest deal DXB negotiated +30% royalties. Yes +30% which is phenomenal. So now we have 2 independent parties thoroughly reviewed the clinical data and said yes and more deals to come. Now getting back to that +30% royalties obvious to me DXB huge cash pile upfront payments not their main objective in future deals but maximizing the return on each drug sale very exciting times ahead.
Latest deal DXB negotiated +30% royalties. Yes +30% which is...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.015(4.11%) |
Mkt cap ! $211.6M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 36.5¢ | $822.1K | 2.156M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 174062 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 29612 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |